Evaluation of the Cellular, Humoral and Mucosal Immune Response in Adults and Elderly Subjects Vaccinated Either With an Inactivated Influenza Vaccine Administered Via the Intradermal Route or an Inactivated Influenza Vaccine Administered Via the Intramuscular Route.
Phase of Trial: Phase II
Latest Information Update: 25 Jun 2015
At a glance
- Drugs Influenza virus vaccine (Primary) ; Influenza virus vaccine (Primary)
- Indications Influenza virus infections; Orthomyxovirus infections
- Focus Adverse reactions; Pharmacodynamics
- Sponsors Sanofi; sanofi pasteur
- 12 Feb 2010 Actual end date (1 Apr 2009) added as reported by ClinicalTrials.gov.
- 12 Feb 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 12 Nov 2008 New trial record.